Edwards Lifesciences

Edwards Lifesciences (NYSE: EW) is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that save and enhance lives. Headquartered in Irvine, California, Edwards Lifesciences has extensive operations in North America, Europe, Japan, Latin America and Asia and currently employs about 6,400 individuals worldwide. For us, helping patients is not a slogan – it's our life’s work. From developing devices that replace or repair a diseased heart valve to creating new technologies that monitor vital signs in the critical care setting, we help ensure that patients regain and even improve their quality of life.
Company Growth (employees)
Type
Public
HQ
Irvine, US
Founded
1958
Size (employees)
11,100 (est)
Edwards Lifesciences was founded in 1958 and is headquartered in Irvine, US

Edwards Lifesciences Office Locations

Edwards Lifesciences has an office in Irvine
Irvine, US (HQ)
1 Edwards Way

Edwards Lifesciences Metrics

Edwards Lifesciences Financial Metrics

Revenue (2016)

$3 b

Revenue growth (2015-16), %

19%

Gross profit

$2.2 b

Gross profit margin (2016), %

73%

Net income (2016)

$569.5 m

Market capitalization (21-Mar-2017)

$19.9 b

Closing share price (21-Mar-2017)

$94.1

Cash (31-Dec-2016)

$930.1 m
Edwards Lifesciences's current market capitalization is $19.9 b.
Edwards Lifesciences's revenue was reported to be $3 b in FY, 2016 which is a 18.8% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$2 b$2.3 b$2.5 b$3 b

Revenue growth, %

14%7%19%

Cost of goods sold

$522.4 m$625.6 m$617.2 m$797.4 m

Gross profit

$1.5 b$1.7 b$1.9 b$2.2 b

Gross profit Margin, %

74%73%75%73%

EBIT

$515.3 m$1.1 b$622.4 m

EBIT margin, %

25%49%25%

Interest income

$4.6 m$6.4 m$7.9 m$10.8 m

Pre tax profit

$515.3 m$1.1 b$622.4 m$737.9 m

Net Income

$391.7 m$811.1 m$494.9 m$569.5 m
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$420.4 m$653.8 m$718.4 m$930.1 m

Accounts Receivable

$302.5 m$288 m$28.7 m$365.5 m

Inventories

$308.9 m$296.8 m$339.9 m$396.6 m

Current Assets

$1.7 b$2.3 b$2 b$2.2 b

PP&E

$421.6 m$442.9 m$482.5 m$580 m

Goodwill

$385.4 m$376 m$628.3 m$626.1 m

Total Assets

$2.7 b$3.5 b$4.1 b$4.5 b

Accounts Payable

$48.4 m$58.2 m$63.9 m$97.1 m

Current Liabilities

$345.6 m$434.4 m$476.2 m$532.5 m

Additional Paid-in Capital

$671.2 m$878.4 m$946.8 m$1.2 b

Retained Earnings

$2 b$2.8 b$3.3 b$3.9 b

Total Equity

$1.6 b$2.2 b$2.5 b$2.6 b

Financial Leverage

1.7 x1.6 x1.6 x1.7 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

$391.7 m$811.1 m$494.9 m$569.5 m

Depreciation and Amortization

$68.7 m$68.6 m$65.8 m$71.2 m

Accounts Receivable

$8.5 m($27 m)($38 m)($57 m)

Inventories

($44 m)($31 m)($68 m)($66 m)

Accounts Payable

Cash From Operating Activities

$472.7 m$1 b$549.7 m$704.4 m

Purchases of PP&E

($15 m)($331.6 m)

Capital Expenditures

($109 m)($82.9 m)($102.7 m)($176.1 m)

Cash From Investing Activities

($412.7 m)($633 m)($316.1 m)($211.7 m)

Cash From Financing Activities

$34.9 m($153 m)($158.6 m)($268.5 m)

Interest Paid

$4.3 m$15.5 m$17.2 m$16.1 m

Income Taxes Paid

$54 m$128.1 m$134.5 m$105.1 m

Free Cash Flow

$581.7 m$1.1 b$652.4 m$880.5 m

Edwards Lifesciences Market Value History

Edwards Lifesciences Median Salaries

Source: 63 public H-1B filings from Edwards Lifesciences

Edwards Lifesciences Online Presence

Edwards Lifesciences News

Edwards Lifesciences Company Life

You may also be interested in